Hansen Medical has announced it will exhibit its Magellan Robotic System at the Global Embolization Symposium and Technologies (GEST) Scientific Meeting 24–27 June at the FIBES II New Conference Centre in Seville, Spain.
During this year’s GEST meeting, the Magellan Robotic System will be featured in a scientific session entitled “Cutting Edge Technology” and in a company sponsored symposium. On 26 June, there will be a discussion about intravascular robotics in the parallel session, titled cutting edge technology in the main auditorium from 2:15 to 3:45pm. This will also see the presentation on robotic-assisted embolization by Marc Sapoval, Paris, France.
Hansen is also sponsoring an educational symposium on Wednesday, June 24 from 6:00 to 6:30 pm, called “Clinical Update on Robotic Embolization.” Two speakers, Marc Sapoval and Mohamad Hamady, London, UK, will discuss the role of robotic technology in providing enhanced precision, control and radiation protection in endovascular procedures. This session will take place in the FIBES II – New Conference Centre, Bruselas Lecture Room.
“The GEST meeting attracts medical experts from all over the world to discuss and debate the latest advances in embolization therapies,” said Cary Vance, Hansen Medical’s president and CEO. “We are excited that Magellan will be discussed as a cutting edge technology. Magellan enables patients to benefit from robotic precision and control in these [embolization] procedures, while helping to protect physicians from the harmful effects of exposure to ionising radiation.”
